home *** CD-ROM | disk | FTP | other *** search
- Path: sparky!uunet!zaphod.mps.ohio-state.edu!rpi!uwm.edu!ogicse!das-news.harvard.edu!cantaloupe.srv.cs.cmu.edu!drycas.club.cc.cmu.edu!pitt.edu!pitt!geb
- From: geb@cs.pitt.edu (Gordon Banks)
- Newsgroups: sci.med
- Subject: Re: Adiposity 101
- Message-ID: <17939@pitt.UUCP>
- Date: 31 Dec 92 17:51:00 GMT
- Article-I.D.: pitt.17939
- References: <1992Dec23.043007.5590@omen.UUCP> <1992Dec23.054435.19318@spdcc.com> <1992Dec23.105556.8340@omen.UUCP>
- Sender: news@cs.pitt.edu
- Reply-To: geb@cs.pitt.edu (Gordon Banks)
- Organization: Univ. of Pittsburgh Computer Science
- Lines: 30
-
- In article <1992Dec23.105556.8340@omen.UUCP> caf@omen.UUCP (Chuck Forsberg) writes:
-
- >No. I mean items in Adiposity 101 such as the one-liner:
- >"Adipocyte Hyperplasia: Excessive number of fat cells, as much
- >as ten times normal.", without adequately explaining the
- >significance of fat cell number.
- >
- Hey, I knew what you were talking about. You said that there were
- new methods that did not increase hyperplasia by 10%, and I said
- I had never heard of any such method where hyperplasia was
- assessed. Certainly the work with fenfluramine did not include
- biopsies did it? Not that I am accepting that cycle dieting
- increases it, since there is no human study that shows that it
- does.
-
- >Steve, you (and others) seem convinced I am excluding relevant,
- >high quality obesity research from Adiposity 101 that doesn't
- >"tell me what I want to hear". Could you be specific? Please
- >discuss specific papers, we've had enough vague generalizations.
- >
-
- Every time I mention one you say "oh, I knew about it, but
- it is pure crap" or something like that. I'm sure you do
- know about them. You just find any paper you don't agree
- with to be crap.
- --
- ----------------------------------------------------------------------------
- Gordon Banks N3JXP | "I have given you an argument; I am not obliged
- geb@cadre.dsl.pitt.edu | to supply you with an understanding." -S.Johnson
- ----------------------------------------------------------------------------
-